BHV-1420

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameBHV-1420
Drug Alias NameBHV-1420BHV1420
ClassificationBiologics > Lysosome-Targeting Chimaeras (LYTAC)
Mechanisms of ActionSecretory phospholipase A2 inhibitorsAsialoglycoprotein receptor binders
TargetsSecretory phospholipase A2Asialoglycoprotein receptor
Therapy Area/IndicationsGlomerulonephritis, Membranous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiohaven Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiohaven Ltd
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, Membranous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A